GNA 11 polymorphisms

摘要

In-vitro method for predicting disease risk, disease progression and pharmaceutical drug risk and for identifying drug targets comprises looking for gene variations in the promoter region and/or intron 1 of the GNA11 gene on human chromosome 19p13.3.